Xbio Systems Overview
- Founded
- 2006
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Xbio Systems General Information
Description
Provider of integrated drug development platform designed to support drug and device development. The company's integrated drug development platform automates workflows and provides advanced content management within a secure, web-based environment.
Contact Information
Website
Formerly Known As
Neuragenix
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Business/Productivity Software
Other Industries
Biotechnology
Automation/Workflow Software
Primary Office
- 225 Market Street
- Suite 500
- Harrisburg, PA 17101
- United States
+1 (717) 000-0000
Xbio Systems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Apr-2016 | 00.000 | Completed | Out of Business | ||
| 3. Convertible Debt | 02-Jul-2008 | 00000 | 00.000 | Completed | Startup | |
| 2. Grant | 23-Jun-2006 | $162K | $2.23M | Completed | Startup | |
| 1. Early Stage VC | 02-Apr-2006 | $2.23M | $2.23M | Completed | Startup |
Xbio Systems Executive Team (6)
Xbio Systems Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Matthew Morgan | Self | Board Member | 000 0000 |
| Steven Godinho | Xbio Systems | Board Member & Chief Executive Officer | 000 0000 |